Cargando…
Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
The huge prognostic difference between early and late stage hepatocellular carcinoma (HCC) is a challenging diagnostic problem. Alpha-fetoprotein is the mostly widely used biomarker for HCC used in the clinic, however it’s sensitivity and specificity of is not optimal. The development and applicatio...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700689/ https://www.ncbi.nlm.nih.gov/pubmed/31435173 http://dx.doi.org/10.3748/wjg.v25.i30.4199 |